| Financial Year |
March 31 2023 |
| Monetary Funds |
355,866,921.87 |
| Held-for-trading Financial Assets |
782,263.65 |
| Notes Receivable |
16,567,109.86 |
| Accounts Receivable |
1,004,552,221.75 |
| Advances to Suppliers |
10,788,912.16 |
| Other Receivables |
9,540,406.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
366,288,632.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,917,785.32 |
| Total Current Assets |
2,178,771,275.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,298,783.59 |
| Investment Properties |
-- |
| Fixed Assetes |
352,075,258.81 |
| Under-construction Projects |
111,580,370.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
179,180,210.35 |
| R&D expenses |
-- |
| Goodwill |
44,215,286.35 |
| Long-Term Deferred and Prepaid Expenses |
5,079,981.20 |
| Deferred Income Tax Assets |
11,660,252.20 |
| Other Non-Current Assets |
12,090,572.26 |
| Sub-Total of Non-Current Assets |
744,483,367.05 |
| Total Assets |
2,923,254,642.91 |
| Short-Term Loans |
285,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
363,290,121.78 |
| Accounts Payable |
277,432,296.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,676,425.50 |
| Taxes Payable |
7,105,696.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,158,908.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,097,666.81 |
| Other Current Liabilities |
466,756.89 |
| Sub-Total of Current Liabilities |
1,043,740,495.15 |
| Long-term Loans |
174,599,999.94 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,404,120.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
209,564,191.83 |
| Total Liabilities |
1,253,304,686.98 |
| Paid-In Capital(Or Share Stock) |
352,326,032.00 |
| Capital Surplus |
620,174,710.04 |
| Surplus Reserve |
78,594,603.48 |
| LESS:Treasury Stock |
6,471,202.25 |
| Undistributed Profits |
613,195,801.96 |
| Minority Stockholder's Interest |
12,130,010.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,657,819,945.23 |
| Owner's Equity（Stockholder's Equity） |
1,669,949,955.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,923,254,642.91 |
